| Date | Title | Description | Source |
| 14.02.2019 | MedImmune brand to be retired as biologics integrate into As... | MedImmune brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
14-02-... | cambridgen... |
| 17.09.2018 | Here’s a look at Maryland’s publicly-traded biotech companie... | When talk turns to Maryland’s biotech bonafides, the ideas and talent being produced by government i... | technical.... |
| 04.05.2018 | Cambridge life sciences cluster set to deliver additional £1... | Cambridge life sciences cluster set to deliver additional £1billion to the UK economy by 2032
04-05-... | cambridgen... |
| 04.08.2017 | Big Pharma veterans at Pfizer, AstraZeneca join the gre... | → Biogen has recruited Anabella Villalobos as its new SVP of biotherapeutic & medic... | endpts.com... |
| 25.05.2017 | Medimmune and UTC Cambridge complete third student Challenge... | Medimmune and UTC Cambridge complete third student Challenge Project
25-05-2017
MedImmune, the globa... | cambridgen... |
| 01.05.2017 | AstraZeneca's bladder cancer drug gets FDA approval | AstraZeneca's bladder cancer drug gets FDA approval
01-05-2017
AstraZeneca and its global biologics ... | cambridgen... |
| 01.05.2017 | AstraZeneca's bladder cancer drug gets FDA approval | AstraZeneca and its global biologics research and development arm, MedImmune, today announced that t... | cambridgen... |
| 30.11.2016 | MedImmune and universities consortium awarded 12 BBSRC biote... | MedImmune and universities consortium awarded 12 BBSRC biotechnology PhD studentships
30-11-2016
Med... | cambridgen... |
| 29.11.2016 | AstraZeneca spins out a bispecific antibody into a ne... | Jane Osbourn, MedImmune
AstraZeneca’s big subsidiary MedImmune and synthetic biology pla... | endpts.com... |
| 03.10.2016 | MedImmune out-licenses potential medicine for inflammatory d... | MedImmune out-licenses potential medicine for inflammatory diseases to Allergan
03-10-2016
AstraZene... | cambridgen... |
| 18.05.2016 | AstraZeneca announces positive results for potential new med... | AstraZeneca announces positive results for potential new medicine for asthma
18-05-2016
AstraZeneca ... | cambridgen... |
| 18.05.2016 | AstraZeneca announces positive results for potential new med... | AstraZeneca has announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal... | cambridgen... |
| 22.04.2016 | AstraZeneca launches integrated genomics approach to drug di... | AstraZeneca and its global biologics research and development arm, MedImmune, today announced an int... | cambridgen... |
| 22.04.2016 | AstraZeneca launches integrated genomics approach to drug di... | AstraZeneca launches integrated genomics approach to drug discovery and development
22-04-2016
Astra... | cambridgen... |
| 09.03.2016 | MedImmune receives fast track designation in the US for infl... | MedImmune receives fast track designation in the US for influenza antibody
09-03-2016
AstraZeneca ha... | cambridgen... |
| 09.03.2016 | MedImmune receives fast track designation in the US for infl... | AstraZeneca has announced that its global biologics research and development arm, MedImmune, has rec... | cambridgen... |
| 12.01.2016 | AstraZeneca and Moderna Therapeutics announce new collaborat... | AstraZeneca and Moderna Therapeutics announce new collaboration
12-01-2016
AstraZeneca, along with i... | cambridgen... |
| 11.12.2015 | AstraZeneca to harness power of the Secretome and develop ne... | AstraZeneca to harness power of the Secretome and develop next-generation biologics
11-12-2015
Astra... | cambridgen... |
| 14.10.2015 | Human Vaccines Project partners with MedImmune | Human Vaccines Project partners with MedImmune
14-10-2015
MedImmune is the newest member of the Huma... | cambridgen... |
| 25.09.2015 | MedImmune and Tanabe Research Laboratories have entered into... | MedImmune and Tanabe Research Laboratories have entered into a strategic collaboration
25-09-2015
Me... | cambridgen... |
| 25.08.2015 | AstraZeneca and Peregrine to collaborate on immuno-oncology ... | AstraZeneca and Peregrine to collaborate on immuno-oncology combination clinical trial
25-08-2015
As... | cambridgen... |
| 06.07.2015 | Dr Jane Osbourn joins Babraham Bioscience Technologies as ne... | Dr Jane Osbourn joins Babraham Bioscience Technologies as new Non-Executive Director
06-07-2015
Babr... | cambridgen... |
| 30.06.2015 | AstraZeneca-University of Cambridge announce joint PhD and c... | AstraZeneca-University of Cambridge announce joint PhD and clinical research scholarships
30-06-2015... | cambridgen... |
| 27.05.2015 | MedImmune and University of Cambridge strengthen partnership | MedImmune and University of Cambridge strengthen partnership
27-05-2015
MedImmune, the global biolog... | cambridgen... |
| 14.05.2015 | AstraZeneca updates on immuno-oncology pipeline and combinat... | AstraZeneca updates on immuno-oncology pipeline and combination treatments at ASCO 2015
14-05-2015
A... | cambridgen... |
| 09.04.2015 | MedImmune's MEDI8897 receives fast track designation by the ... | MedImmune's MEDI8897 receives fast track designation by the FDA
09-04-2015
MedImmune, the global bio... | cambridgen... |
| 09.04.2015 | MedImmune's MEDI8897 receives fast track designation by the ... | MedImmune, the global biologics research and development arm of AstraZeneca, announced today that it... | cambridgen... |
| 20.03.2015 | MedImmune establishes collaboration with São Paulo Research ... | MedImmune establishes collaboration with São Paulo Research Foundation, Brazil
20-03-2015
MedImmune ... | cambridgen... |
| 10.03.2015 | MedImmune and Joslin Diabetes Center collaborate on advancin... | MedImmune and Joslin Diabetes Center collaborate on advancing metabolic disease research
10-03-2015
... | cambridgen... |
| 20.02.2015 | MedImmune and NIST partner to advance development of biologi... | MedImmune and NIST partner to advance development of biological therapies
20-02-2015
MedImmune, the ... | cambridgen... |
| 03.02.2015 | Combacte-Magnet: another new project to revitalise antibotic... | Combacte-Magnet: another new project to revitalise antibotic development
03-02-2015
Today 33 Europea... | cambridgen... |
| 02.02.2015 | First patient enrolled in the new Drugs 4 Bad Bugs Programme | First patient enrolled in the new Drugs 4 Bad Bugs Programme
02-02-2015
Two years after the start of... | cambridgen... |
| 17.11.2014 | MedImmune presents promising new data in systemic lupus | MedImmune presents promising new data in systemic lupus
17-11-2014
MedImmune, the global biologics r... | cambridgen... |
| 17.11.2014 | MedImmune presents positive Phase IIB data for rheumatoid ar... | MedImmune presents positive Phase IIB data for rheumatoid arthritis treatment
17-11-2014
MedImmune, ... | cambridgen... |
| 08.10.2014 | MedImmune in-licenses acute coronary syndrome biologic resea... | MedImmune in-licenses acute coronary syndrome biologic research program from Shionogi
08-10-2014
Med... | cambridgen... |
| 05.06.2014 | MedImmune and Ventana Medical Systems, Inc. collaborate for ... | MedImmune and Ventana Medical Systems, Inc. collaborate for immunotherapy clinical trials
05-06-2014... | cambridgen... |
| 15.05.2014 | AstraZeneca to demonstrate strength of its oncology pipeline... | AstraZeneca to demonstrate strength of its oncology pipeline at ASCO
15-05-2014
New data from AstraZ... | cambridgen... |
| 13.05.2014 | Key MedImmune molecules meet primary endpoints in Phase II s... | Key MedImmune molecules meet primary endpoints in Phase II studies
13-05-2014
AstraZeneca announced ... | cambridgen... |
| 13.05.2014 | AstraZeneca to present respiratory data at ATS 2014 Internat... | AstraZeneca to present respiratory data at ATS 2014 International Conference
13-05-2014
Benralizumab... | cambridgen... |
| 08.05.2014 | AstraZeneca initiates phase III immunotherapy study for MEDI... | AstraZeneca initiates phase III immunotherapy study for MEDI4736 in patients with lung cancer
08-05-... | cambridgen... |
| 30.04.2014 | MedImmune expands University System of Maryland research col... | MedImmune, the global biologics research and development arm of AstraZeneca, and the University Syst... | cambridgen... |
| 30.04.2014 | MedImmune expands University System of Maryland research col... | MedImmune expands University System of Maryland research collaboration
30-04-2014
MedImmune, the glo... | cambridgen... |
| 14.03.2014 | MedImmune and MD Anderson join forces to advance cancer immu... | MedImmune and MD Anderson join forces to advance cancer immunotherapy
14-03-2014
MedImmune, AstraZen... | cambridgen... |
| 09.01.2014 | MedImmune and Immunocore enter immunotherapy agreement to de... | MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies
09-01-2014
... | cambridgen... |
| 26.11.2013 | MedImmune celebrates 25 years of biotech innovation | MedImmune celebrates 25 years of biotech innovation
26-11-2013
MedImmune, the global biologics resea... | cambridgen... |
| 12.11.2013 | MedImmune scientist wins Royal Society of Chemistry Educatio... | MedImmune scientist wins Royal Society of Chemistry Education Award
12-11-2013
MedImmune, the global... | cambridgen... |
| 31.10.2013 | AstraZeneca advances Medimmune's benralizumab to Phase III i... | AstraZeneca advances Medimmune's benralizumab to Phase III in severe asthma
31-10-2013
AstraZeneca h... | cambridgen... |
| 16.10.2013 | MedImmune Cambridge supports Society of Biology’s ‘Big Biolo... | MedImmune Cambridge supports Society of Biology’s ‘Big Biology Day’
16-10-2013
MedImmune Cambridge w... | cambridgen... |
| 15.10.2013 | MedImmune and Auven invest USD 40 million in ADC Therapeutic... | | startuptic... |
| 03.09.2013 | Inspiring the next wave of bio innovation | Inspiring the next wave of bio innovation
03-09-2013
The forthcoming 'Beating the odds in biobusines... | cambridgen... |
| 18.06.2013 | MedImmune and NGM Biopharmaceuticals link for research on di... | MedImmune and NGM Biopharmaceuticals link for research on diabetes and obesity
18-06-2013
AstraZenec... | cambridgen... |
| 18.03.2013 | AstraZeneca shakes up R&D division with 1,600 staff cuts... | The pharmaceutical company said shifting its R&D sites to “bioscience hot spots” will make it ea... | medcitynew... |
| 25.07.2012 | Biopharmaceutical firm NuPathe co-founder and CEO exits, ent... | Incoming CEO and board member Armando Anido has 30 years of experience in the pharmaceutical industr... | medcitynew... |
| 02.04.2012 | Former head of Sanofi vaccines division becomes infectious d... | Last year, it was granted a five-year research grant valued up to $196 million by the Biomedical Adv... | medcitynew... |
| 13.12.2011 | Catabasis Pharmaceuticals Raises $8M in Extended Series A Fi... | Catabasis Pharmaceuticals, a Cambridge, Mass.-based clinically staged company dedicated to the disco... | finsmes.co... |
| 28.11.2011 | CorMedix adds pharmaceutical veteran to board of directors | CorMedix (NYSE:CRMD), a Bridgewater, New Jersey-based therapeutic product developer for the preventi... | medcitynew... |
| 16.09.2009 | FDA approves four H1N1 flu vaccines, no shortage expected â€... | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis h... | medcitynew... |
| 29.10.2008 | BioLogix bags $6M for oncology drug, names new CEO | Biopharm company BioLogix raised $6 million in first-round equity and debt financing from Essex Wood... | venturebea... |
| 17.10.2008 | MedImmune expands R&D capacity with new research facilit... | MedImmune expands R&D capacity with new research facility in Cambridge
17-10-2008
MedImmune open... | cambridgen... |
| 07.03.2008 | Life-science briefing: Friday, March 7, 2008 | TODAY’S HEADLINES:
Allegro pulls in $4M for lung-cancer molecular diagnostics (release)
Ocular banda... | venturebea... |
| 23.08.2007 | A biotech flu vaccine and the seduction of hype | (UPDATED: See below.)
Vaccine developer Protein Sciences is all over the blogosphere today (see, for... | venturebea... |
| 23.04.2007 | AstraZeneca ups the biotech ante | Now that AstraZeneca has made the bold — or impulsive — decision to snap up MedImmune for $15.6 bill... | venturebea... |
| 16.04.2007 | Biotech financing: Are early-stage companies hot again? | (Note: This item has been copied over to the Life Sciences page from its original location on the Ve... | venturebea... |
| 16.04.2007 | Biotech financing: Are early-stage companies hot again? | Venture investors’ interest in early-stage biotech companies may finally be starting to revive, near... | venturebea... |
| 19.07.2002 | US biotech firm MedImmune launches $100m venture fund | Their decision provides further evidence of the attractiveness of the biotech sector for venture inv... | altassets.... |
| - | FDA approves four H1N1 flu vaccines, no shortage expected â€... | Image via Wikipedia
WASHINGTON, D.C. – The U.S. Food and Drug Administration has approved four va... | medcitynew... |
| - | CorMedix adds pharmaceutical veteran to board of directors | CorMedix (NYSE:CRMD), a Bridgewater, New Jersey-based therapeutic product developer for the preventi... | medcitynew... |
| - | AstraZeneca shakes up R&D division with 1,600 staff cuts... | AstraZeneca (NYSE:AZN) is revamping its research and development divisions to improve drug developme... | medcitynew... |
| - | Former head of Sanofi vaccines division becomes infectious d... | The former head of Sanofi’s (NYSE:SNY) vaccines division, one of the largest vaccine companies in th... | medcitynew... |
| - | Biopharmaceutical firm NuPathe co-founder and CEO exits, ent... | Biopharmaceutical firm NuPathe’s (NASDAQ:PATH) CEO Jane Hollingsworth has resigned as CEO and board ... | medcitynew... |
